Acne Clinical Trials

A 52-week, multicenter, randomized, double-blind study of secukinumab (300mg) to demonstrate efficacy as assessed by psoriasis area and severity index and investigator's global assessment after 12 weeks of treatment, compared to ustekinumab, and to assess long-term safety, tolerability, and efficacy in subjects with moderate to severe plaque psoriasis.

Let's face acne together! If you or your child has moderate to severe acne, we invite you to join our investigational drug study of a topical treatment foam. Eligibility Criteria: -Adults or children at least 9 years of age or older -You must have at least 20 red, irritated pimples ...

ActivMed Practices and Research is looking for volunteers to participate in a research study for moderate to severe acne.

If you or your child has moderate to severe acne, we invite you to join our investigational drug study of a topical treatment foam.

A 12 week clinical trial seeking patients for a research study for the treatment of Moderate to Severe Acne Vulgaris? Volunteers will receive compensation for time, travel and study-related medical care. Qualified participants may receive study medications and all study related care including physical examinations and laboratory services at no ...

Acne

Schweiger Dermatology in New York is conducting a research study of an investigational medication for moderate to severe acne.

Research Across America in Dallas is conducting a research study of an investigational medication for moderate to severe acne.

Assessment of the efficacy and safety of CD5789 50µg/g cream applied once daily for 12 weeks in subjects with moderate facial and truncal acne vulgaris.

This acne research study is for those 9 and older (those 17 and younger must have a parent/legal guardian to sign consent) who have facial acne as well as body acne. The study compares different topical acne products. Study details include: Ages 9 and older with moderate facial acne AND ...